Results 191 to 198 of about 8,556 (198)
Some of the next articles are maybe not open access.
Exclusive patent, know-how, process and technology license, including improvements, to develop, use, manufacture, register, market, sell, package, label and sublicense ophthalmic formulations that contain P1,P4-Di(Uridine 5'-Tetraphosphate), based on purinergic receptor agonists, to treat ocular surface diseases in humans, including dry eye.
2000 openaire +1 more source
